astragaloside a has been researched along with Colorectal Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chongming, A; Tingxin, L; Xirong, H; Ziyang, T | 1 |
| Chen, L; He, H; Liu, F; Ran, F | 1 |
| Chen, D; Liu, Y; Su, L; Ye, Q; Zheng, W | 1 |
| Cui, L; Mou, J; Wang, S; Wang, X; Zhang, Z | 1 |
| Liu, Y; Sun, P; Wang, Q; Zhang, B | 1 |
| Ding, D; Huang, J; Lei, S; Lin, F; Liu, X; Ma, J; Mao, D; Shi, L; Zhang, S; Zhang, Y | 1 |
| Li, SL; Li, Y; Luo, HF; Xie, T | 1 |
1 review(s) available for astragaloside a and Colorectal Neoplasms
| Article | Year |
|---|---|
The potential molecular pathways of Astragaloside-IV in colorectal cancer: A systematic review.
Topics: Apoptosis; Colorectal Neoplasms; Humans; Multicenter Studies as Topic; Saponins; Triterpenes | 2023 |
6 other study(ies) available for astragaloside a and Colorectal Neoplasms
| Article | Year |
|---|---|
Astragaloside IV Exerts Anti-tumor Effect on Murine Colorectal Cancer by Re-educating Tumor-Associated Macrophage.
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Colorectal Neoplasms; Cytokines; Drug Therapy, Combination; Female; Humans; Immune Checkpoint Inhibitors; Mice; Mice, Inbred BALB C; Programmed Cell Death 1 Receptor; Saponins; Th1 Cells; Th2 Cells; Triterpenes; Tumor Microenvironment; Tumor-Associated Macrophages | 2020 |
Astragaloside IV Induced miR-134 Expression Reduces EMT and Increases Chemotherapeutic Sensitivity by Suppressing CREB1 Signaling in Colorectal Cancer Cell Line SW-480.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Cyclic AMP Response Element-Binding Protein; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Organoplatinum Compounds; Oxaliplatin; Saponins; Signal Transduction; Triterpenes | 2017 |
Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3.
Topics: B7 Antigens; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclin D1; Cyclin-Dependent Kinase 4; Down-Regulation; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Resting Phase, Cell Cycle; RNA, Messenger; Saponins; Triterpenes; Up-Regulation | 2018 |
Astragaloside IV inhibits human colorectal cancer cell growth.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; HT29 Cells; Humans; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Saponins; Triterpenes; Tumor Burden; Xenograft Model Antitumor Assays | 2019 |
[Inhibitory effect of jianpi-jiedu prescription-contained serum on colorectal cancer SW48 cell proliferation by mTOR-P53-P21 signalling pathway].
Topics: Animals; Apigenin; Blotting, Western; Cell Cycle; Cell Division; Cell Proliferation; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Drugs, Chinese Herbal; Flow Cytometry; Ginsenosides; Glycyrrhizic Acid; Humans; Lactones; Phosphorylation; RNA, Messenger; Saponins; Sesquiterpenes; Signal Transduction; TOR Serine-Threonine Kinases; Triterpenes; Tumor Suppressor Protein p53 | 2016 |
Astragaloside IV Enhances Cisplatin Chemosensitivity in Human Colorectal Cancer via Regulating NOTCH3.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Colorectal Neoplasms; HCT116 Cells; Humans; Receptor, Notch3; RNA, Messenger; Saponins; Triterpenes; Up-Regulation | 2016 |